Literature DB >> 29856566

The long-term treatment of schizophrenia with antipsychotics: a perennial debate.

W Wolfgang Fleischhacker1.   

Abstract

Entities:  

Year:  2018        PMID： 29856566      PMCID： PMC5980630          DOI： 10.1002/wps.20542

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis.

Authors:  Hiroyuki Uchida; Takefumi Suzuki; Hiroyoshi Takeuchi; Tamara Arenovich; David C Mamo
Journal:  Schizophr Bull       Date:  2009-11-27       Impact factor: 9.306

2.  How precise is precision medicine for schizophrenia?

Authors:  Lynn E DeLisi; W Wolfgang Fleischhacker
Journal:  Curr Opin Psychiatry       Date:  2016-05       Impact factor: 4.741

3.  Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.

Authors:  G Chouinard; B D Jones
Journal:  Am J Psychiatry       Date:  1980-01       Impact factor: 18.112

Review 4.  The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.

Authors:  Donald C Goff; Peter Falkai; W Wolfgang Fleischhacker; Ragy R Girgis; Rene M Kahn; Hiroyuki Uchida; Jingping Zhao; Jeffrey A Lieberman
Journal:  Am J Psychiatry       Date:  2017-05-05       Impact factor: 18.112

5.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.

Authors:  Lex Wunderink; Roeline M Nieboer; Durk Wiersma; Sjoerd Sytema; Fokko J Nienhuis
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

Review 6.  Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

Authors:  Robin M Murray; Diego Quattrone; Sridhar Natesan; Jim van Os; Merete Nordentoft; Oliver Howes; Marta Di Forti; David Taylor
Journal:  Br J Psychiatry       Date:  2016-11       Impact factor: 9.319

7.  Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.

Authors:  Stefan Leucht; Magdolna Tardy; Katja Komossa; Stephan Heres; Werner Kissling; Georgia Salanti; John M Davis
Journal:  Lancet       Date:  2012-05-03       Impact factor: 79.321

8.  Relating Spontaneously Reported Extrapyramidal Adverse Events to Movement Disorder Rating Scales.

Authors:  Christian G Widschwendter; Onur N Karayal; Sheela Kolluri; Douglas Vanderburg; Georg Kemmler; W Wolfgang Fleischhacker
Journal:  Int J Neuropsychopharmacol       Date:  2015-06-26       Impact factor: 5.176
  8 in total
  1 in total

Review 1.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.